Similar Search Results

Narrow search

Patent licensing, entry and the incentive to innovate

Tauman, Yair; Zhao, Chang - 2017

Persistent link: https://www.econbiz.de/10011698585

Promoting Jordan's use of compulsory licensing during the pandemic

Barqawi, Laila - 2023

Persistent link: https://www.econbiz.de/10014364285

TRIPS flexibilities and access to medicines : an evaluation of barriers to employing compulsory licenses for patented pharmaceuticals at the WTO

Wong, Anna S. Y.; Cole, Clarke B.; Kohler, Jillian Clare - 2022

without the patent owner's authorization by issuing a compulsory license (CL). In the pharmaceuticals space, governments have … historically employed compulsory licenses to compel originator manufacturers to license their patents to generic manufacturers … refrain from issuing compulsory licenses. A survey of members' domestic compulsory license legislation finds that virtually …

Persistent link: https://www.econbiz.de/10013469578

The WTO TRIPS decision on COVID-19 vaccines : what is needed to implement it?

Correa, Carlos María; Syam, Nirmalya - 2022

the COVID-19 pandemic that are manufactured under a compulsory license or government use authorization to other developing …

Persistent link: https://www.econbiz.de/10013469582

Twenty years after Doha : an analysis of the use of the TRIPS Agreement's public health flexibilities in India

Abbas, Muhammad Zaheer - 2022

The World Trade Organization (WTO) linked intellectual property protection with trade. The WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), however, included a number of public health flexibilities in order to provide latitude to the Member States to...

Persistent link: https://www.econbiz.de/10013258010

Analysis of COVID-related patents for antibodies and vaccines

Santhanam, Kausalya - 2023

This paper provides an analysis of patents covering selected antibodies and vaccines used in the treatment or prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the...

Persistent link: https://www.econbiz.de/10014233696

Lessons from India's implementation of Doha Declaration on TRIPS and Public Health

Batra, Nanditta - 2022

The major bone of contention between the developed and developing countries in the TRIPS negotiations was patents for pharmaceuticals. The US-led developed countries bloc argued in favour of patents for pharmaceuticals amidst opposition from Brazil, India and other countries. Ample evidence,...

Persistent link: https://www.econbiz.de/10013393634